Kevin Buczkowski, DPM
Foot & Ankle Surgery · Brockton, MANPI 1891316477
Payments from drug & device makers
What this record shows
The money is spread across several categories — education (53.4%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. 12 manufacturers reported payments, led by Kairos Surgical Inc at 54.2% of the total. Reporting peaked in 2022 at $1,930 and has fallen 67.7% since, to $624 in 2025.
Across 52 payments — averaging $86.45 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Kairos Surgical Inc$2K
- Integra Lifesciences Corporation$595
- Smith+Nephew$356
- Kerecis Limited$310
- Arthrex$201
- Carbofix Orthopedics Inc$138
- plus $461 from 6 others
What the payments were for
- Travel & lodging$1614%
- Food & beverage$1,93443%
- Education$2,40053%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Kairos Surgical Inc | 4 | $2,434 |
| Integra Lifesciences Corporation | 13 | $595 |
| Smith+Nephew | 18 | $356 |
| Kerecis Limited | 4 | $310 |
| Arthrex | 3 | $201 |
| Carbofix Orthopedics Inc | 1 | $138 |
| Lifenet Health | 1 | $127 |
| Avita Medical Americas, LLC | 2 | $125 |
| Trilliant Surgical LLC. | 1 | $90 |
| Bioventus LLC | 3 | $67 |
| Treace Medical Concepts, Inc. | 1 | $35 |
| Orthofix Medical, Inc. | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,495 in reported general payments places this provider in the 70th percentile of 122 foot & ankle surgery providers in Massachusetts.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ciclopirox | 20 | $459 |
| Diclofenac Sodium | 15 | $280 |
| Terbinafine Hcl | 22 | $207 |
| Methylprednisolone | 23 | $169 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 11 | $142 |
| Oxycodone Hcl | 29 | $128 |
| Meloxicam | 26 | $103 |
| Doxycycline Hyclate | 11 | $95 |
| Cephalexin | 12 | $82 |
Paid to pharmacies, not to this prescriber.
Other foot & ankle surgery in Brockton
- Harry SchneiderCambridge$174K
- Craig LareauSpringfield$115K
- David SipalaBrighton$94K
- Philip BasileCambridge$90K
- Michael SgangaNatick$90K
- Joseph FleckNorth Chelmsford$35K
- Michael SkoniecznyPlymouth$33K
- Richard BakerHyannis$16K
- Mark SlovenkaiWaltham$14K
- Jaeyoung KimBoston$14K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.